Skip to content

Trial Summary

This observational study is collecting information from patients to form the Myeloma and Related Diseases Registry (MRDR)

Acronym:

MRDR

ACTRN/NCT /ethics:

ACTRN12618000659202

Scientific title:

Myeloma and related disease registry

Sponsor / Cooperative group:

Monash University

Trial & Patient Characteristics

Cancer TypeOther
Trial TypeEarly detection, diagnosis, prognosis
PhaseAll phases
Age Range18 years and older
SexAll
Tumour Stream Myeloma
Cancer StageAll stages
Anticipated Start Date2020-09-11
Anticipated End Date2026-12-31

Participating Hospitals

HospitalIcon Cancer Centre Adelaide
Clinical Trial CoordinatorSue Yeend
Emailsue.yeend@icon.team
Phone08 8292 2204
Principal InvestigatorDr Stanley Cheung
Recruitment StatusRecruiting